首页 | 本学科首页   官方微博 | 高级检索  
检索        

超声造影诊断肝包膜下小肝癌的临床价值
引用本文:毛枫,袁海霞,范培丽,曹佳颖,王文平.超声造影诊断肝包膜下小肝癌的临床价值[J].中国肿瘤临床,2020,47(11):563-566.
作者姓名:毛枫  袁海霞  范培丽  曹佳颖  王文平
作者单位:①.复旦大学附属中山医院超声科(上海市 200032)
基金项目:上海市临床重点专科项目shslczdzk03501上海市自然科学基金项目19ZR1450700
摘    要:目的:探讨超声造影对肝包膜下小肝癌的诊断价值。方法:选取2017年1月至2019年7月间临床表现或其他影像学诊断怀疑为肝包膜下肝癌的51例患者,分析其常规超声和超声造影的表现,并总结其特征。结果:51例患者,共53个病灶,经手术、介入、临床表现或影像学检查证实。所有病灶均位于肝脏包膜下,45个病灶紧贴肝包膜,8个病灶位于肝包膜下10 mm以内。肝包膜下病灶以等回声和稍高或稍低回声为主,占90.6%(48/53),肿块边界不清和欠清者占94.3%(50/53)。超声造影显示53个病灶中48个表现为动脉期快速增强,同步增强5个。门脉期38个病灶减退呈低回声,占71.7%(38/53);15个病灶呈等回声,占28.3%(15/53);延迟期50个病灶减退呈低回声,3个病灶仍呈等回声改变。53个病灶中,超声造影检查符合"快进快出"类型38个,占71.7%(38/53);"快进慢出"类型12个,占22.6%(12/53);"快进不出"类型3个,占5.7%。常规超声检出15个病灶,检出率为28.3%(15/53),超声造影检出53个病灶,检出率为100%(53/53),两种方法比较差异有统计学意义(P<0.01)。结论:超声造影对肝包膜下小肝癌具有很高的检出率,值得在临床应用。

关 键 词:超声  超声造影  肝包膜下肝癌  检出率
收稿时间:2020-03-31

Clinical value of contrast-enhanced ultrasound in the diagnosis of subcapsular small liver cancer
Feng Mao,Haixia Yuan,Peili Fan,Jiaying Cao,Wenping Wang.Clinical value of contrast-enhanced ultrasound in the diagnosis of subcapsular small liver cancer[J].Chinese Journal of Clinical Oncology,2020,47(11):563-566.
Authors:Feng Mao  Haixia Yuan  Peili Fan  Jiaying Cao  Wenping Wang
Institution:①.Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai 200032, China②.Shanghai Institute of Medical Imaging, Shanghai 200032, China
Abstract:  Objective  To evaluate the value of contrast-enhanced ultrasound (CEUS) in the diagnosis of subcapsular small liver cancer.  Methods  Fifty-one patients diagnosed with subcapsular liver cancer by ultrasound or other imaging between January 2017 and July 2019 were enrolled. The manifestations of conventional ultrasound and contrast-enhanced ultrasonography were analyzed, and the characteristics, summarized.  Results  There were a total of 53 lesions, all of which were confirmed on the basis of surgical findings, clinical manifestations, or imaging findings. All lesions were located under the liver capsule. Forty-five lesions were located close to the liver capsule, whereas 8 lesions were located within 10 mm from the liver capsule. Of the subcapsular lesions, 90.6% (48/53) were isoechoic and slightly higher or lower echoic, and 94.3% (50/53) had unclear boundaries. CEUS revealed rapid arterial enhancement in 48 of 53 lesions and synchronous enhancement in 5 lesions. In the portal phase, 38 lesions (71.7%) presented hypoechoic changes, and 15 lesions presented isoechoic changes. In the delayed phase, 50 lesions (94.3%) presented hypoechoic changes, and 3 lesions presented isoechoic changes. Among the 53 lesions, the "fast in and fast out" type was found in 38 cases (71.7%) and the "fast in and slow out" type, in 12 cases (22.6%). There were also 3 cases (5.7%) of "fast in and no out" type. Conventional ultrasound revealed 15 lesions, with a detection rate of 28.3% (15/53), and contrast-enhanced ultrasound revealed 53 lesions, with a detection rate of 100% (53/53). The difference between the two methods was statistically significant (P < 0.01).  Conclusion  Contrast-enhanced ultrasound has a high detection rate for subcapsular small liver cancer and has a significant clinical value. 
Keywords:ultrasound  contrast-enhanced ultrasound(CEUS)  subcapsular liver cancer  detection rate
本文献已被 维普 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号